211 related articles for article (PubMed ID: 17845992)
1. [Prognostic factors of localised, locally advanced or metastatic prostate cancer].
Joly F; Henry-Amar M
Bull Cancer; 2007 Jul; 94(7 Suppl):F35-43. PubMed ID: 17845992
[TBL] [Abstract][Full Text] [Related]
2. Prostate Risk Index (PRIX) as a new method of risk classification for clinically localized prostate cancer.
Yoshioka Y; Inoue T
Strahlenther Onkol; 2007 Sep; 183(9):490-6. PubMed ID: 17762923
[TBL] [Abstract][Full Text] [Related]
3. Cross-cultural validation of a prognostic tool: example of the Kattan preoperative nomogram as a predictor of prostate cancer recurrence after radical prostatectomy.
Rouprêt M; Hupertan V; Comperat E; Drouin SJ; Phé V; Xylinas E; Demanse D; Sibony M; Richard F; Cussenot O
BJU Int; 2009 Sep; 104(6):813-7; discussion 817-8. PubMed ID: 19254280
[TBL] [Abstract][Full Text] [Related]
4. [Locally advanced prostate cancer: definition, prognosis and treatment].
Plantade A; Massard C; de Crevoisier R; Fizazi K
Bull Cancer; 2007 Jul; 94(7 Suppl):F50-61. PubMed ID: 17845994
[TBL] [Abstract][Full Text] [Related]
5. [Prognosis and predictive factors in prostate cancer].
Albiges-Sauvin L; Lévy A; Massard C; Fizazi K
Bull Cancer; 2009 Apr; 96(4):439-49. PubMed ID: 19357018
[TBL] [Abstract][Full Text] [Related]
6. [Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer--a multi-institutional update].
Graefen M
Aktuelle Urol; 2004 Sep; 35(5):377-8. PubMed ID: 15384003
[No Abstract] [Full Text] [Related]
7. Oncologic outcome and patterns of recurrence after salvage radical prostatectomy.
Paparel P; Cronin AM; Savage C; Scardino PT; Eastham JA
Eur Urol; 2009 Feb; 55(2):404-10. PubMed ID: 18639970
[TBL] [Abstract][Full Text] [Related]
8. Local-regional prostate cancer.
Jones MJ; Koeneman KS
Urol Oncol; 2008; 26(5):516-21. PubMed ID: 18774466
[TBL] [Abstract][Full Text] [Related]
9. Predicting the risk of patients with biopsy Gleason score 6 to harbor a higher grade cancer.
Gofrit ON; Zorn KC; Taxy JB; Lin S; Zagaja GP; Steinberg GD; Shalhav AL
J Urol; 2007 Nov; 178(5):1925-8. PubMed ID: 17868725
[TBL] [Abstract][Full Text] [Related]
10. Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients.
May M; Knoll N; Siegsmund M; Fahlenkamp D; Vogler H; Hoschke B; Gralla O
J Urol; 2007 Nov; 178(5):1957-62; discussion 1962. PubMed ID: 17868719
[TBL] [Abstract][Full Text] [Related]
11. How often do available preoperative risk factors accurately predict the risk assessed after surgery for localized prostate cancer?
Laudano MA; Lambert SM; Masson P; McCann TR; Desai M; Benson MC; McKiernan JM
BJU Int; 2009 Feb; 103(3):317-20. PubMed ID: 18778341
[TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy.
Fuchsjäger MH; Shukla-Dave A; Hricak H; Wang L; Touijer K; Donohue JF; Eastham JA; Kattan MW
BJU Int; 2009 Aug; 104(3):315-20. PubMed ID: 19220263
[TBL] [Abstract][Full Text] [Related]
13. Tumour length of the largest focus predicts prostate-specific antigen-based recurrence after radical prostatectomy in clinically localized prostate cancer.
Mizuno R; Nakashima J; Mukai M; Okita H; Kosugi M; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Oya M
BJU Int; 2009 Nov; 104(9):1215-8. PubMed ID: 19389009
[TBL] [Abstract][Full Text] [Related]
14. Gleason Pattern 5 prostate cancer: further stratification of patients with high-risk disease and implications for future randomized trials.
Nanda A; Chen MH; Renshaw AA; D'Amico AV
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1419-23. PubMed ID: 19131185
[TBL] [Abstract][Full Text] [Related]
15. PSA in the new millennium: a powerful predictor of prostate cancer prognosis and radical prostatectomy outcomes--results from the SEARCH database.
Freedland SJ; Hotaling JM; Fitzsimons NJ; Presti JC; Kane CJ; Terris MK; Aronson WJ; Amling CL
Eur Urol; 2008 Apr; 53(4):758-64; discussion 765-6. PubMed ID: 17868976
[TBL] [Abstract][Full Text] [Related]
16. Ki-67 in screen-detected, low-grade, low-stage prostate cancer, relation to prostate-specific antigen doubling time, Gleason score and prostate-specific antigen relapse after radical prostatectomy.
Khatami A; Hugosson J; Wang W; Damber JE
Scand J Urol Nephrol; 2009; 43(1):12-8. PubMed ID: 18949633
[TBL] [Abstract][Full Text] [Related]
17. PSA velocity is associated with gleason score in radical prostatectomy specimen: marker for prostate cancer aggressiveness.
Loeb S; Sutherland DE; D'Amico AV; Roehl KA; Catalona WJ
Urology; 2008 Nov; 72(5):1116-20; discussion 1120. PubMed ID: 18571700
[TBL] [Abstract][Full Text] [Related]
18. Decreased immunostaining for macrophage scavenger receptor is associated with poor prognosis of prostate cancer.
Takayama H; Nonomura N; Nishimura K; Oka D; Shiba M; Nakai Y; Nakayama M; Tsujimura A; Aozasa K; Okuyama A
BJU Int; 2009 Feb; 103(4):470-4. PubMed ID: 18778349
[TBL] [Abstract][Full Text] [Related]
19. Role of surgery in treatment of locally advanced prostate cancer.
Prezioso D; Galasso R; Di Martino M; Iapicca G; Iacono F
Anticancer Res; 2006; 26(4B):3151-8. PubMed ID: 16886649
[TBL] [Abstract][Full Text] [Related]
20. PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume.
Whitman EJ; Groskopf J; Ali A; Chen Y; Blase A; Furusato B; Petrovics G; Ibrahim M; Elsamanoudi S; Cullen J; Sesterhenn IA; Brassell S; Rittenhouse H; Srivastava S; McLeod DG
J Urol; 2008 Nov; 180(5):1975-8; discussion 1978-9. PubMed ID: 18801539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
